Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Summit Therapeutics Inc’s current trading price is -41.90% away from its 52-week high, while its distance from the 52-week low is 1100.61%. The stock’s price range over this period has fluctuated between $1.64 and $33.89. The company, operating within the financial sector, had a trading volume of approximately 2.95 million for the day, which was noticeably lower than the average daily share volume of 4.93 million over the last 3 months.
Summit Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $33.89 on 09/16/24, while the lowest value for the same period was recorded at $1.64 on 11/09/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Summit Therapeutics Inc (SMMT) has experienced a quarterly rise of 137.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.26B and boasts a workforce of 105 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.17, with a change in price of +15.20. Similarly, Summit Therapeutics Inc recorded 5,241,734 in trading volume during the last 100 days, posting a change of +338.53%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for SMMT stands at 0.56. Similarly, the long-term debt-to-equity ratio is also 0.03.
SMMT Stock Stochastic Average
Today, Summit Therapeutics Inc’s raw stochastic average for the past 50 days stands at 43.22%, indicating a rise from the raw stochastic average of the last 20 days, which was 9.96%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 11.62% and 19.29% respectively.
SMMT Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 654.41% this year. Over the last six months, there has been a weaker performance of 382.60%. The price of SMMT fallen by 2.87% during the last 30 days period. For the last 5-days stocks have slided -2.04%.
